ESR1 and cancer: ERα inhibits the TGFβ signaling pathway by binding to Smad2 and Smad3 which repress the proliferation of cancer cell; in addition, MTA3 (Metastatic Tumor Antigen 3), a suppressor of Snai1, is upregulated by ERα.